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Background.  Although heart-to-mediastinum (H/M) ratio in a planner image has been 
used for practical quantification for 123I-metaiodobenzylguanidine (MIBG) imaging, 
standardization of the parameter is not yet established. We hypothesized that the value 
of H/M can be standardized to the various types of camera-collimator combinations.  
Methods and Results. Standard phantoms consisting of the heart, mediastinum were 
made. A low-energy high-resolution (LEHR) collimator, and medium-energy (ME) 
collimator were used. We examined multi-window correction methods with 123I- dual-
window (IDW) acquisition and planar images were obtained with IDW with LEHR. The 
images were obtained by using GCA-9300A (Toshiba Co., Ltd.), E.CAM Signature 
(Toshiba Co., Ltd, Tokyo) and Varicam (GE, Tokyo). Cardiac phantom studies 
demonstrated contamination of the H/M count ratio was greater with LEHR collimator 
and least with the ME collimator. The H/M ratio with collected LEHR collimator was 
similar to that with ME collimators. The uncorrected H/M ratio in ME collimator had a 
linear relationship with the corrected H/M ratio by IDW method in LEHR collimator. 
The relationship between uncorrected LEHR (Toshiba GCA9300A) and ME collimator 
is y= 0.56 x + 0.49: y=H/M in e.cam, x=H/M in ME collimator. The averages of the 
normal values for the low-energy type collimator (n=18) was 2.2 + 0.2 (initial H/M), 
2.42 + 0.2 (delayed H/M), and 2.63 + 0.25 (initial H/M), 2.87 + 0.19 delayed H/M) for 
low-medium-energy (LME) collimator (n=14). H/M value in previous clinical studies 
using LEHR was comparable to that of ME collimators. 
Conclusions.  The H/M ratio with corrected LEHR, after application of the IDW 
method, was similar to that of ME collimator. This finding could make it possible to 
standardize planar imaging of the H/M ratio among various collimators in clinical 
setting.   
Abbreviations: MIBG:metaiodobenzylguanidine, collimator, iodine-dual-energy 
window method
       TEXT 
  123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy has been widely 
used to evaluate the cardiac sympathetic system [1-21]. Because sympathetic activity is 
enhanced with increasing severity of congestive heart failure, the severity and prognosis 
of congestive heart failure can be evaluated based on parameters determined by 123I-
MIBG scintigraphy [2,3,7].  The evaluation of severity or prognosis of heart failure is 
considered as class I evidence in Japanese Circulation Society guidelines for nuclear 
cardiology use [1]. Parameters obtained with late MIBG scintigraphy images such as 
heart/mediastinum (H/M) ratio and washout rate can be used as indicators for 
sympathetic activity.  Patients with the lowest uptake of MIBG have the poorest 
prognosis [10, 17]. Normal value of H/M differs in each institution [3]. Although 123I-
MIBG studies have been accepted for clinical routine use in many countries, 
standardization of MIBG parameter is not yet fully performed. Without proper 
validation and standardization, the use of 123I-MIBG might be limited to a single center 
research tool for understanding the physiology of myocardial sympathetic nerve 
activities under different conditions [3].  A standardized method for measuring MIBG 
uptake in various gamma camera systems is required in clinical setting [3]. The effect of 
collimator choice substantially influences the estimation of H/M ratio. Low-energy 
collimators are often applied to cardiac 123I-MIBG imaging. However, Inoue et al 
reported that the medium-energy (ME) collimators provided high quantitative accuracy 
and may enhance reliability in the MIBG study [4]. The H/M ratio with the ME 
collimator, after application of multi-window methods, was close to the theoretical 
value in the phantom study [5].  
 We hypothesized that the value of H/M can be standardized in various 
camera-collimator combinations. The improvements in quantification can 
be better achieved by a multiple-window approach [5]. In this study we 
performed phantom experiments to assess quantitative value in 123I-MIBG 
H/M ratio with low energy high resolution (LEHR) collimator and ME 
collimator using various types of gamma camera to make correction among 
collimators.  Moreover, we aimed to validate the phantom studies and 
previous clinical studies in order to achieve proper standardization.  
 
Methods 
Preparation of Phantoms      The phantom was designed for measuring the planar 
H/M ratio [5]. Because the purpose of this study was to standardize the H/M ratio 
among different collimator types and manufacturers by eliminating septal penetration 
and scatter, we tried to simplify the structure as much as possible, as previously reported 
[5]. In short, each organ part was designed so that the radioactivity was distributed 
uniformly in the organ region of interest (ROI). The size of the phantom was 380 mm in 
width and length, and the thickness of the each organ was flat and constant. The 
thickness of each organ part was adjusted by changing the number of slices. Four types 
of acrylic slice parts, with a thickness of 5 mm per slice, were combined and arranged 
into various numbers and orders. In the phantom studies, true H/M ratios were 
mathematically calculated in these models, assuming the linear attenuation coefficient 
(μ) of 123I for water as 0.147/cm. The standard equation for attenuation, that is e-μx, 
where x was thickness of attenuation, was used. A slice was divided into 0.05 mm of 
thin slices, and the summation of the count was calculated using Mathematica software 
(version 5.2, Wolfram Research, Inc., Champaign, I11, USA). The phantom 
measurement was repeated with and without three acrylic plates (9.7 mm/plate) over the 
phantom as scatter media. The H/M could be calculated, with anterior and posterior 
views from the two phantoms (Table 1). 
Data Acquisition and Correction Methods   Planar images were simultaneously 
obtained with five energy windows, and were combined to make three correction 
methods, i.e., windows 1 to 5 were 132-142, 143-175, 176-186, 187-208, and 209-294 
keV. The 123I dual-window (IDW) method used an energy window on the high-energy 
side to estimate the number of scattered 529-keV photons, in which an original upper 
window (176-208 keV, IDW0) by Motomura et al [18] and a wide upper window (176-
294 keV, IDW1) were examined. The energy window setting is shown in Figure 1. The 
IDW method subtracted mainly septal penetration counts by rectangular approximation. 
The original IDW methods used Butterworth filtering for subwindow images, and 
subtracted the filtered image from the main-window image. However, in this study, no 
image subtraction was performed, to avoid a decrease in count and an increase in noise 
even after filtering. Subwindow images were used only for calculating the counts on the 
same ROIs as the main window. 
 
Collimators   For the phantom study, low-energy high-resolution (LEHR) and 
medium-energy (ME) collimators were used. The special resolution was 7.4, 10.1, and 
7.6 mm for LEHR, ME, and low-medium-energy high resolution (LMEHR) collimators 
at a collimator-to-source distance of 10 cm, respectively. The sensitivity of the 
collimators was 5.5, 6.1, and 5.4 cpm/kBq, respectively. The LEHR of three 
manufactured companies were used to measure H/M. The images were obtained using 
the following SPECT camera systems: E.CAM signature in Kanazawa University 
Hospital (Toshiba Co. Limit, Tokyo, Japan/Siemens), GSA 9300A in Kanazawa 
University Hospital (Toshiba, Tochigi, Japan) and Varicam in Kanazawa Cardiovascular 
Center (GE Medical Systems, Tokyo, Japan). 
For clinical studies, data from working group of Japanese Society of Nuclear Medicine 
for myocardial SPECT standardization (chief investigator: Kenichi Nakajima) were 
used [22]. A low-medium-energy general purpose (LMEGP) collimator (in Shizuoka 
Cancer Center: E.CAM), specifically designed for 123I high-energy photons, was also 
used to calculate H/M. And low-energy general purpose (LEGP) collimators (in Toho 
University Hospital) were also used to determine H/M. These two collimators were used 
to examine H/M in 28 patients without heart disease as a clinical study.  
Method of clinical study    Thirty-three patients without heart disease were enrolled 
in this study [15 females and 18 males, aged 52+22]. The 123I-MIBG (111 MBq) was 
injected intravenously, and the planar images were obtained using gamma cameras 
(Toshiba, Tochigi, Japan) with LEHR collimators in 14 patients, and with LME 
collimator in 14 patients. For this study, anterior images were obtained again 3 hours 
after injection with both LEGP and LME collimators.  
Data Processing for H/M Ratios   The ROIs were set over the heart and the upper third 
of the mediastinum on the main-window image. The same ROIs were used to measure 
the count on the five subwindow images. The H/M ratios were calculated by average 
heart count divided by average mediastinal count. 
Statistics   Dara analysis was done using a computer-based programme, ‘The 
statistical Discovery Software’, JMP IN (version 5.0.1, SAS institute, Cary, USA). 
Average counts in ROIs were used for image data analysis. Statistics of the average and 
standard deviation (SD) were calculated. An analysis of variance for the mean was 
performed, based on groups with collimator types and correction methods. A paired t 
test was also used for the comparison of correction methods. A linear regression line for 




Phantom Study: LEHR vs.ME 
  Mathematically calculated H/M was listed in Table 1. There was a clear difference in 
image quality between LEHR and ME collimators(Fig. 2). Planar data were higher for 
ME than LEHR collimators among three cameras (Table 2).  
   Table 3 shows the calculated H/M ratios divided by uncorrected H/M 
ratio with ME collimator. The no corrected H/M ratio with a LEHR 
collimator was from 0.85 + 0.08. On the other hand, the result from 
corrected H/M ratio with IDW0 was 1.01 + 0.05, and the corrected H/M 
ratio with IDW1 was 1.0 + 0.02. 
Phantom Study: corrected LEHR vs. ME 
Uncorrected H/M in LEHR had a linear relationship with H/M in ME collimator. 
Uncorrected LEHR (Toshiba, E.CAM) vs. ME collimator 
y= 0.56 x + 0.49 (y=H/M in E.CAM, x=H/M in ME collimator) 
Uncorrected LEHR (Toshiba, GCA9300A) vs. ME collimator 
y = 0.59 x + 0.49 (y=H/M in Toshiba, GCA9300, x=H/M in ME collimator) 
Uncorrected LEHR (GE Varicam) vs. ME collimator 
y = 0.61 x + 0.52 (y=H/M in GE, Varicam, x=H/M in ME collimator) 
 The relationship between the uncorrected H/M ratio with the ME collimator, and the 
H/M ratios with the LEHR collimator are shown in figure 3. The uncorrected H/M ratio 
in ME collimator had a linear relationship with the corrected H/M ratio by IDW method 
in LEHR collimator.  
 Table 4 shows the coefficient of correlation and p value for the correlation between the 
uncorrected H/M of the ME collimator and the IDW-collected H/M of LEHR collimator.  
 
Clinical Studies 
 The averages of the normal values for the low energy type collimator (LEGP and 
LEHR) (n=18) was 2.2+0.2 (initial H/M), 2.3+0.2 (delayed H/M), and corrected normal 
values using the correction reference of the methods above (GE, Varicam) were 2.7+0.3 
(initial H/M), 3.0+0.3 (delayed H/M). 
 The averages of the normal values for LMEGP collimator (n=14) were 2.6 + 0.3 
(initial H/M) and 2.9 + 0.2 (delayed H/M).   
 To analyze the distribution of H/M with each collimator, box plats were generated for 
LE type, LME, corrected LE type (Figure 2). There was a significant difference in initial 
H/M and delayed H/M between LE type and LME (initial, 2.2 + 0.2 vs. 2.6 + 0.3, 
p<0.05; delayed, 2.3 + 0.2 vs. 2.9 + 0.2, p<0.05). After using correction reference of 
IDW method, there was no significant difference in initial H/M and delayed H/M 
between corrected LE type and LME (initial, 2.7 + 0.3 vs 2.6 + 0.3; delayed 3.0 + 0.4 vs 





   This study showed that the application of IDW correction methods provided 
comparable values to the uncorrected data from ME collimator, and that this was 
applicable to various types of gamma camera, including manufactures such as GE, 
Siemens and Toshiba. The application of IDW correction methods with the LEHR 
collimators of these companies yielded values comparables to those with the ME 
collimator. Therefore the value of H/M can be standardized in various camera-
collimator combinations with IDW correction. Moreover in clinical situation, the IDW 




  As we have previously reported that the H/M ratio with the ME collimators, or after 
application of the TEW or IDW methods, was close to theoretical value in the phantom 
study [5,23]. Because H/M ratio is computed from count in relatively large regions, it 
may be inferred from that septal penetration that takes precedence over high resolution. 
Former clinical studies could divide into two groups of collimators, one is 123I-specific 
collimators, including ME collimator and LME collimator [5]. These collimators have 
characteristics that septal penetration is low, providing high quantitative accuracy. 
Another group of collimator is designed mainly for 99mTc, not 123I-specific like LEHR, 
LEGP collimator. Comparatively large amount of septal penetration tend to make H/M 
value smaller.  
  
Scatter-corrected H/M 
 123I gamma photon radiation included a 529 keV component in 1.39% of the total 
number of photons [20]. Therefore, the number of scattered photons from 529 keV 
component depends on the physical characteristics of the collimators. Moreover, the 
high-energy photon causes a significant amount of septal penetration, and the high 
background activity was the results of multiple complex scatters. The scatter 
distribution and septal penetration comes with a broad distribution all over the field of 
view, that was also shown in the image of the 187 to 209-keV and 210 to 294-keV 
windows [20]. The distribution of septal penetration did not seem to reflect the real 
structure of tracer distribution. Scatter correction method, IDW is one of the 
commercially available methods. IDW is effective to eliminate this septal penetration 
from the high-energy photon [3-5].  In the present phantom study, the three different 
camera systems with corrected LEHR collimators produced similar semi-quantitative 
planar H/M ratios, which is comparable to that of ME collimators (Table 3). Apparently, 
ME collimator or LME collimators, which are specific to 123I, plays an important role 
in reducing variability in the results. In order to make it feasible to make comparison 
between institutions or to compare previous clinical data, the results in this study might 
be useful. The understanding of collimator choice may help to achieve the 
standardization in MIBG values. H/M ratio with ME collimator or corrected LEGP 
collimator may be a simple method which allows comparison of inter-individual and 
inter-institutional results, by correcting for differences in body geometry and attenuation 
between individual subjects. 
 
  Clinical significance  
   The acquisition of MIBG imaging with IDW method is simple and has a high 
reproducibility. This method is applicable to almost all institution, since this is not 
complicated as before and does not need special facility. We can not only understand 
numerous studies of past MIBG imaging by the correction, but also use the IDW 
methods in acquiring MIBG imaging from now on. Actually we recommend all 
institution should use the IDW methods as a gold standard in calculating MIBG H/M.  
   In published 123I-MIBG studies, we could divide into two groups of values of H/M, 
although the precise collimator information was not available from all studies. In one 
group, the delayed H/M ratio ranged from 2.1 to 2.4, using LEHR or LEGP collimators 
[7,14,24,25]. Another group showed a comparatively higher delayed H/M ratio, from 
2.8 to 3.0. using ME collimator or LME collimator [9,11]. The results of this study 
confirmed this hypothesis that corrected value of H/M with 123I-nonspecific collimator 
comes near to that of 123I-specific collimators and that the H/M ratio with collected 
LEHR, after application of the IDW method, was similar to that of ME collimator [3,5]. 
By examining human 123I-MIBG data in various collimators in this study, it turned out 
that we can apply phantom results to clinical data. Technical improvement with IDW 
method can facilitate the acquisition of comparable results of various collimators, which 
is of clinical importance for investigations in multicenter collaborations. 
  123I-MIBG values have been demonstrated by numerous studies to have 
prognostic values in congestive heart failure patients [7,10,17]. Although 
some study were conducted by ME collimator, many hospitals now 
continue to use low-energy collimators, and most of the previous data were 
accumulated by using low-energy collimators. Therefore, the result of this 
study makes it possible to compare these results among previous studies. 
The results of this phantom will help to calibrate inter-institutional 
differences in H/M ratio. Furthermore this study showed the possibility of 
using LEHR collimators were used with the scatter correction of IDW 
method as a standardization of MIBG H/M ratio. The corrected value of 
H/M can be used in different camera-collimator combinations. 
 
Limitation 
 As a factor that influences MIBG H/M, the difference of setting region of interest 
(ROI) is one of the big factors. We used same ROI in evaluating the planar imaging. A 
method to set the shape of the ROI has to be standardized, and this could be a limitation. 
Automatic selection would improve reproducibility among institutions. 
 
  In conclusions, The H/M ratio with collected LEHR, after application of the IDW 
method, was similar to that of ME collimator. The scatter-corrected method with IDW 
method could make it possible to standardize planar imaging of the H/M ratio among 
various collimators in clinical setting.  
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tables and figures 
 
 
Table 1  Phantom types and mathematically calculated H/M ratios        
 Ratio of thickness              Mathematically calculated H/M 
  Heart Mediastinum   Ant. Post.                
Type B 6 2   2.6 3.50 
Type D 5 3   1.55 1.80                 
 




Table 2  Planar H/M ratios obtained from phantom study: LEHR vs. ME vs. LMEHR  
(Anterior phantom B) 
 
 IDW0 IDW1 No Correction     Mathematically caculated H/M
LEHR 2.13  2.27  1.76  2.60 
MEGP 2.46  2.53  2.26  2.60  
LMEHR 2.36  2.41  2.12  2.60 
 
LEHR, low-energy high resolution; MEGP, medium-energy general purpose;  LMEHR, 
low medium-energy high resolution; H/M, heart-to-mediastinum count ratio; IDW, 123I 
dual-window.  
 
Table 3.  Phantom MIBG study 
Divided by uncorrected H/M ratio with ME collimator 
       Type D   Type B 
 Ant. Post. Ant. Post.
IDW0 LEHR     
     Toshiba/Siemens:ECAM 0.98 0.99 0.94 0.96 
     GE;Varicom 1.10 1.02 1.04 1.08 
     Toshiba:GSA9300 1.02 1.01 1.02 1.04 
IDW1 LEHR     
     Toshiba/Siemens:EC AM 1.00 1.02 1.00 1.02 
     GE:Varicom 1.05 1.01 0.97 1.00 









The coefficient of correlation and p value for the correlation between the uncorrected 
H/M of the ME collimator and the IDW-collected H/M of LEHR collimator 
    R  p-value   
IDW0-collected LEHR 
Toshiba/Siemens:ECAM  0.998  0.0012 
GE:Varicom   0.994  0.0031 
Toshiba:GSA9300  0.994  0.0031    
IDW1-collected LEHR 
Toshiba/Siemens:ECAM  0.999  0.0005 
GE:Varicom   0.995  0.0035 
Toshiba:GSA9300  0.999  0.0003    
IDW, 123I dual-window; H/M, heart-to-mediastinum count ratio; ME, medium-energy; 
LEHR, low-energy high resolution. 
Figure 1 
Schematic representation of the 123I dual-window (IDW) methods. Sub energy 
windows are shown with the energy spectrum of 123I obtained with the low-energy 




Images of five energy windows with the medium-energy (ME) and low-energy high 
resolution (LEHR) collimators. The maximum count is shown in the image and 
normalized to 100% for each image. The left panel of the 143 to 175-keV image was 
obtained in the main window.   
 
Figure 3 
Relationship between the uncorrected heart-to-mediastinum (H/M) ratio with the 
mediam-energy (ME) collomator, and the H/M ratios with the low-energy-high-
resolution (LEHR) collimator. Green lines shows the relationship between uncorrected 
H/M in LEGP and H/M with ME collmators. Red lines shows corrected H/M with IDW 






Box plots of the variability of H/M. The box indicates a median with upper and lower 
quartiles (defined as 75th and 25th percentiles) and upper and lower bars indicate 90th 
and 10th percentiles, respectively. 
LE-i, initial low-energy type; LME-I, low medium-energy high resolution; c-LE-i, 
initial corrected low-energy type; d, delayed. NS, not significant    
 
 
 




